drugset / Trial / NCT03031691
A Study of Brontictuzumab With Chemotherapy for Subjects With Previously Treated Metastatic Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
A Phase 1b Dose Escalation Study of the Safety and Pharmacodynamics of Brontictuzumab in Combination with Chemotherapy for Subjects with Previously Treated Metastatic Colorectal Cancer.
Timeline
- Start
- 2017-01
- Primary completion
- 2017-05
- Completion
- 2017-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Brontictuzumab | Monoclonal antibody | 1.5 mg/kg | Intravenous |
| Background | trifluridine/tipiracil | Unknown | — | — |